Related Experiment Video
Updated: Jul 30, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage
S W Jones1, S M V Brockbank, M L Mobbs
1Respiratory and Inflammation Research Area, Alderley Park, AstraZeneca, Macclesfield SK10 4TG, United Kingdom. simon.w.jones@astrazeneca.com
Objective:
RDC1 is a class A orphan G-protein coupled receptor of unknown function. The purpose of this study was to identify compound RDC1 agonists and use these as tools to determine the effect of RDC1 activation in human chondrocytes and cartilage explant tissue.
Methods:
Computational chemistry was employed to build a homology model of the RDC1 receptor. A virtual screen of in-house compounds was then performed and positive hits screened for their ability to invoke a Ca2+ response in a recombinant RDC1 HEK293 cell line, as measured by FLIPR. The effect of RDC1 activation on human chondrocytes and cartilage explant gene expression was determined by quantitative real-time polymerase chain reaction (PCR), and these effects validated as being mediated by RDC1 using siRNA antisense.
Results:
Tissue expression profiling demonstrated that RDC1 expression was predominant in cartilage tissue. Treatment of human primary chondrocytes with RDC1 agonist induced a Ca2+ response, suggesting the receptor is active in this tissue type. Treatment for 24h with RDC1 agonist led to altered expression of a number of genes associated with chondrocyte hypertrophy and increased matrix degradation in human primary chondrocytes, and elevated total matrix metalloproteinase (MMP) activity in cartilage explant. Transfection with RDC1 siRNA caused a >90% reduction in human primary chondrocyte RDC1 expression and significantly reduced the impact of RDC1 agonist on the previously identified RDC1-regulated genes.
Conclusions:
RDC1 activation in human chondrocytes and cartilage explant leads to changes in gene expression and activity associated with chondrocyte hypertrophy, angiogenesis and increased matrix degradation, suggesting signalling via the RDC1 receptor may play an important role in the early development of osteoarthritis (OA).
Insights
Activation of the RDC1 receptor in human cartilage cells influences genes linked to hypertrophy and matrix breakdown. This suggests RDC1 signaling may be crucial in early osteoarthritis development.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- RDC1 is a class A orphan G-protein coupled receptor with an uncharacterized function.
- Understanding RDC1's role is essential for investigating cellular processes and potential disease mechanisms.
Purpose of the Study:
- To identify agonists for the RDC1 receptor.
- To investigate the functional consequences of RDC1 activation in human chondrocytes and cartilage.
Main Methods:
- Computational chemistry and virtual screening were used to identify RDC1 agonists.
- Functional assays included calcium (Ca2+) response measurement (FLIPR), gene expression analysis (quantitative real-time PCR), and siRNA-mediated knockdown.
Main Results:
- RDC1 expression is highest in cartilage tissue.
- RDC1 activation in chondrocytes induced a Ca2+ response and altered gene expression related to hypertrophy and matrix degradation.
- RDC1 activation increased matrix metalloproteinase (MMP) activity in cartilage explants.
Conclusions:
- RDC1 activation in human chondrocytes and cartilage leads to gene expression and activity changes associated with chondrocyte hypertrophy, angiogenesis, and matrix degradation.
- RDC1 signaling may play a significant role in the early pathogenesis of osteoarthritis (OA).
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Cell Polarization by Rho Proteins
Growth of Cartilage and Bone Tissue
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway

